News
The PSMAddition trial shows 177Lu PSMA-617 significantly delays progression in mHSPC when added to hormone therapy, with a ...
5d
Clinical Trials Arena on MSNNovartis reports topline outcomes from trial of Pluvicto for prostate cancerNovartis has reported topline outcomes from the Phase III PSMAddition trial’s pre-specified interim analysis of Pluvicto.
Novartis (NYSE:NVS) announced positive topline results from the Phase III PSMAddition trial, which showed that its targeted ...
Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive mHSPC: Basel Tuesday, June 3, 2025, 12:00 Hrs [IST] ...
Dead smartphones aren’t so smart. If you travel, stay away from home for extended periods of time or simply forget to charge your phone occasionally, it might be wise to keep a portable charger ...
At a median follow-up of 60.7 months, patients in the combination arm of enzalutamide + leuprolide had significantly superior 5-year metastasis free survival rates (87.3% versus 71.4%; HR: 0.42, 95% ...
Slack Tide Fish Co. is set to open today, Friday, June 6 at the Ballast complex in Scott’s Addition at 1320 Summit Ave. Chef Caleb Shriver is heading up the space, formerly of Dutch & Co., a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results